Recommendation ID
DG11/2
Question
Further research is needed on the impact of faecal calprotectin testing on clinical decision-making when added to current practice. This includes research into optimal cut-off values for tests and the investigation of repeat testing strategies in people with intermediate levels of faecal calprotectin. Development of a consistent definition for the 'intermediate range' is encouraged.
Any explanatory notes
(if applicable)
None.

Source guidance details

Comes from guidance
Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel
Number
DG11
Date issued
October 2013

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 14/11/2013